Correction: Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells
Mikaella Vouri, Qian An, Matthew Birt, Geoffrey J. Pilkington, Sassan Hafizi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPhagocytosis and Immune Regulation
This article has been corrected: The authors discovered a duplication error in Figure 4C, where the pAkt blot for SNB-19 cells was mistakenly duplicated in place of the pAkt blot for UP007 cells.
The authors have provided uncropped Western blots for pAkt and Axl for both cell lines and replaced the incorrect image with the correct one from the original experiments. The band densitometry results, derived from the true original blots, remain unchanged and accurately displayed in the graphs.
This inadvertent error does not compromise the validity or integrity of the study’s findings, and this correction does not affect the conclusions of the study. The corrected Figure 4C, produced from the original data, is shown below.
Original article: Oncotarget. 2015; 6:16183–16197. 16183-16197. https://doi.org/10.18632/oncotarget.3952